Alto Ingredients Receives Medical Ingredient Certification

Rhea-AI Summary

Alto Ingredients, Inc. (NASDAQ: ALTO) has announced that its Illinois Corn Processing (ICP) facility has received the EXCiPACT Good Manufacturing Practices (GMP) certification. This certification aligns with the company’s growth strategy to expand its presence in various ethyl alcohol markets, complementing its ISO 9001 and ICH Q7 certifications. The EXCiPACT certification is recognized globally within the pharmaceutical industry, indicating Alto's commitment to quality and safety in drug formulation components. This achievement underscores the company's effort to meet customer demands for high-quality ingredients.

Positive

• Achieved EXCiPACT GMP certification for the ICP facility, enhancing credibility in the pharmaceutical market.
• Supports growth strategy by broadening access to ethyl alcohol markets.
• Compliments existing ISO 9001 and ICH Q7 certifications, reinforcing quality commitment.

Negative

• None.

ICP Facility Now Certified Pharmaceutical Excipient Supplier

SACRAMENTO, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer of specialty alcohols and essential ingredients, announced its Illinois Corn Processing (ICP) facility is now 2017 EXCiPACT Good Manufacturing Practices (GMP) certified.

“A key component of our growth strategy is broadening our access to additional ethyl alcohol markets,” said Mike Kandris, CEO. “In conjunction with our recently announced ISO 9001 and ICH Q7 certifications, our EXCiPACT certification accomplishes that goal. EXCiPACT is an independent, globally recognized certification standard for the use of excipients in the pharmaceutical industry. Excipients are the inactive components of a drug or medication, such as solvents, carriers or tinctures. We attained these quality certifications with the assistance of our customers who expect high quality, safe ingredients for use in their formulations. These certifications demonstrate our commitment to meeting those expectations.”

About EXCiPACT
Regulators require excipient users to qualify their suppliers based on GMP/GDP audits. Regulators have indicated that third-party auditing of suppliers is acceptable if a creditable certification body issues certificates and audit reports by employing qualified auditors who are demonstrably credible in suitable GMP/GDP standards and in the needs of the pharmaceutical industry. EXCiPACT is a non-profit organization that owns and manages oversight of such an independent, high quality, third-party certification program available to pharmaceutical excipient manufacturers and distributors worldwide. For more information please visit https://www.excipact.org/

About Alto Ingredients, Inc.
Alto Ingredients, Inc. (ALTO), formerly known as Pacific Ethanol, Inc., is a leading producer of specialty alcohols and essential ingredients. The company is focused on products for four key markets: Health, Home & Beauty; Food & Beverage; Essential Ingredients; and Renewable Fuels. The company’s customers include major food and beverage companies and consumer products companies. For more information please visit www.altoingredients.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Statements and information contained in this communication that refer to or include Alto Ingredients’ estimated or anticipated future results or other non-historical expressions of fact are forward-looking statements that reflect Alto Ingredients’ current perspective of existing trends and information as of the date of the communication. Forward looking statements generally will be accompanied by words such as “anticipate,” “believe,” “plan,” “could,” “should,” “estimate,” “expect,” “forecast,” “outlook,” “guidance,” “intend,” “may,” “might,” “will,” “possible,” “potential,” “predict,” “project,” or other similar words, phrases or expressions. Such forward-looking statements include, but are not limited to, statements concerning Alto Ingredients’ plans, objectives, expectations and intentions. It is important to note that Alto Ingredients’ objectives, expectations and intentions are not predictions of actual performance. Actual results may differ materially from Alto Ingredients’ current expectations depending upon a number of factors affecting Alto Ingredients’ business. These factors include, among others, adverse economic and market conditions, including for specialty alcohols and essential ingredients; export conditions and international demand for the company’s products; fluctuations in the price of and demand for oil and gasoline; raw material costs, including production input costs, such as corn and natural gas; and the effects – both positive and negative – of COVID-19; and Alto Ingredients’ ability to maintain and benefit from quality management certifications. These factors also include, among others, the inherent uncertainty associated with financial and other projections; the anticipated size of the markets and continued demand for Alto Ingredients’ products; the impact of competitive products and pricing; the risks and uncertainties normally incident to the specialty alcohol production and marketing industries; changes in generally accepted accounting principles; successful compliance with governmental regulations applicable to Alto Ingredients’ distilleries, products and/or businesses; changes in laws, regulations and governmental policies; the loss of key senior management or staff; and other events, factors and risks previously and from time to time disclosed in Alto Ingredients’ filings with the Securities and Exchange Commission including, specifically, those factors set forth in the “Risk Factors” section contained in Alto Ingredients’ Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 16, 2020.

Media Contact:                 

Bryon McGregor, Alto Ingredients, Inc., 916-403-2768, mediarelations@altoingredients.com

Company IR Contact:                 

Michael Kramer, Alto Ingredients, Inc., 916-403-2755, Investorrelations@altoingredients.com

IR Agency Contact:

Moriah Shilton, LHA Investor Relations, 415-433-3777, Investorrelations@altoingredients.com

FAQ

What does the EXCiPACT certification mean for Alto Ingredients?

The EXCiPACT certification signifies that Alto Ingredients' ICP facility adheres to Good Manufacturing Practices, enhancing its credibility and access to the pharmaceutical excipient market.

How will the certification impact ALTO's growth strategy?

The certification supports ALTO's growth strategy by broadening access to ethyl alcohol markets and meeting customer demands for high-quality ingredients.

What other certifications does Alto Ingredients have besides EXCiPACT?

In addition to EXCiPACT, Alto Ingredients also holds ISO 9001 and ICH Q7 certifications.

When was the EXCiPACT certification announced by Alto Ingredients?

The EXCiPACT certification was announced on February 4, 2021.